English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12340/13512 (91%)
Visitors : 2255540      Online Users : 242
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Patents [0/70]
    Periodical Articles [160/160]
    Conference Papers/Meeting Abstract [23/37]

    Community Statistics


    Item counts issued in 3 years:27(10.11%)
    Items With Fulltext:183(68.54%)

    Download counts of the item
    Download times greater than 0:183(100.00%)
    Download times greater than 100:177(96.72%)
    Total Bitstream Download Counts:100780(1.78%)

    Last Update: 2025-03-12 21:24

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 126-150 of 267. (11 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2017-05 1-(2,4-Dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one: A novel opioid receptor agonist with less accompanying gastrointestinal dysfunction than morphine Anesthesiology. 2017 May;126(5):952-966.
    2017-04 A novel CXCR4 antagonist CX549 induces neuroprotection in stroke brain Cell Transplantation. 2017 Apr;26(4):571-583.
    2017-04 Discovery of BPR1K871-a quinazoline based multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation Abstracts of Papers of the American Chemical Society. 2017 Apr;253:Meeting Abstract 482.
    2016-12 Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation Oncotarget. 2016 Dec;7(52):86239-86256.
    2016-12 Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST Annals of Oncology. 2016 Dec;27(Suppl. 9):Meeting Abstract 2P.
    2016-10 BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia Molecular Cancer Therapeutics. 2016 Oct;15(10):2323-2333.
    2016-10 Multifunctional nanoparticles for oral protein drug delivery Diabetes Research and Clinical Practice. 2016 Oct;120(Suppl. 1):S19.
    2016-08 Dipeptidyl peptidase-4 inhibitor LAF-237 improves glucose tolerance and expends graft beta cell mass in diabetic mice transplanted with a sufficient number of islets Diabetologia. 2016 Aug;59(Suppl. 1):S198.
    2016-07-12 Dipicolylamine derivatives and their pharmaceutical uses US9388193/2016-07-12
    2016-05-30 항암 경구 제제 KR10-1627382/2016-05-30
    2016-05 N-Indolylglycosides bearing modifications at the glucose C6-Position as Sodium-Dependent Glucose Co-transporter 2 inhibitors Bioorganic and Medicinal Chemistry. 2016 May;24(10):2242-2250.
    2016-02 Multifunctional nanoparticles for oral protein drug delivery Nanomedicine: Nanotechnology, Biology and Medicine. 2016 Feb;12(2):463.
    2015-09 Self-assembling bubble carriers for oral protein delivery Biomaterials. 2015 Sep;64:115-124.
    2015-08 Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38alpha/MAPKAPK-2 and PK-N3 signaling pathway Chemical Research in Toxicology. 2015 Aug ;28(9):1681-1692.
    2015-08 Zinc-dipicolylamine directed pharmaceutical delivery system (ZAPS) as an innovative cancer drug delivery platform Cancer Research. 2015 Aug;75(Suppl. 15):Abstract number 4413.
    2015-08 Optimization of quinazoline-based kinase inhibitors: Identification of a dual FLT3/AURKA kinase inhibitor for the treatment of acute myeloid leukemia Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 490.
    2015-07 Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations European Journal of Medicinal Chemistry. 2015 Jul;100:151-161.
    2015-04 IL-1beta promotes malignant transformation and tumor aggressiveness in oral cancer Journal of Cellular Physiology. 2015 APR;230(4):875-884.
    2015-03 Stem cell mobilizers targeting chemokine receptor CXCR4: Renoprotective application in acute kidney injury Journal of Medicinal Chemistry. 2015 Mar;58(5):2315-2325.
    2014-11 Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent European Journal of Cancer. 2014 Nov;50(Suppl. 6):92-93.
    2014-10 YYEI motif is critical to oncogenicity of 14-3-3 proteins Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3527.
    2014-10 Novel irreversible EGFR tyrosine kinase inhibitor, DBPR112, as a therapeutic candidate for lung adenocarcinoma Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 1756.
    2014-08-15 Anticancer oral formulation JP5596680/2014-08-15
    2014-08-04 Effects of dipeptidyl peptidase-4 inhibition with MK-0431 on syngeneic mouse islet transplantation International Journal of Endocrinology. 2014 Aug 4;2014:Article ID 795283.
    2014-06-04 抗癌口服制剂 CN102159541/2014-06-04

    Showing items 126-150 of 267. (11 Page(s) Totally)
    << < 1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback